| Biguanides |
Valid Value (%) |
NV/NA (%) |
|
| Valid Value |
83941 ( 84.4) |
0 ( 0.0) |
83941 ( 84.4) |
| NV/NA |
15545 ( 15.6) |
0 ( 0.0) |
15545 ( 15.6) |
|
99486 (100.0) |
0 ( 0.0) |
99486 (100.0) |
Table 5.2.9.2.1 : Biguanides (by Type of Diabetes)
| CMH Chi-Square |
p.value |
df |
| 47021.8203 |
0 |
1 |
|
Barplot 5.2.9.2.1 - Biguanides (by Type of Diabetes)
| Biguanides |
Type 1 (%) |
Type 2 (%) |
|
| Yes |
685 ( 7.0) |
36969 ( 49.8) |
37654 ( 44.9) |
| No |
9040 ( 93.0) |
37247 ( 50.2) |
46287 ( 55.1) |
|
9725 ( 11.6) |
74216 ( 88.4) |
83941 (100.0) |
Table 5.2.9.2.2 : Biguanides (by Type of Diabetes)
| CMH Chi-Square |
p.value |
df |
| 6356.6949 |
0 |
1 |
|
Barplot 5.2.9.2.2 - Biguanides (by Type of Diabetes)
|
Barplot 5.2.9.2.2a - Biguanides (by Data Source, Type of Diabetes = Type 1)
|
Barplot 5.2.9.2.2b - Biguanides (by Data Source, Type of Diabetes = Type 2)
| s |
O |
E |
N |
CR |
AR |
C.I. (95%) |
[O-E]/E % |
C.I. [O-E]/E (95%) |
| 01 |
5 |
0 |
39 |
12.8 |
100.0 |
( 0.0;100.0) |
Inf |
( -Inf; Inf) |
| 18 |
35 |
25 |
242 |
14.5 |
9.9 |
( 7.2; 12.5) |
40.0 |
( 14.4; 65.6) |
| 04 |
176 |
157 |
2399 |
7.3 |
7.9 |
( 6.8; 9.0) |
12.1 |
( -4.1; 28.3) |
| 08 |
12 |
11 |
166 |
7.2 |
7.7 |
( 3.5; 11.9) |
9.1 |
(-54.1; 72.3) |
| 12 |
259 |
238 |
3318 |
7.8 |
7.7 |
( 6.8; 8.5) |
8.8 |
( -3.1; 20.8) |
| 16 |
114 |
106 |
1619 |
7.0 |
7.6 |
( 6.3; 8.9) |
7.5 |
(-12.1; 27.2) |
| 06 |
51 |
74 |
1006 |
5.1 |
4.9 |
( 3.3; 6.4) |
-31.1 |
(-51.7;-10.4) |
| 10 |
33 |
70 |
936 |
3.5 |
3.3 |
( 1.7; 4.9) |
-52.9 |
(-74.0;-31.8) |
| T |
685 |
|
9725 |
7.0 |
|
|
|
|
Table 5.2.9.2.3 - Standardized Estimates:
5.2.9.2 Oral therapy in adults w diabetes: Biguanides
(Type of Diabetes = Type 1 )
|
Barplots (Adjusted Rates): 5.2.9.2.1 5.2.9.2 Oral therapy in adults w diabetes: Biguanides - Type of Diabetes = Type 1
|
Forest plots: 5.2.9.2.1 5.2.9.2 Oral therapy in adults w diabetes: Biguanides - Type of Diabetes = Type 1
| s |
O |
E |
N |
CR |
AR |
C.I. (95%) |
[O-E]/E % |
C.I. [O-E]/E (95%) |
| 01 |
317 |
209 |
400 |
79.2 |
76.2 |
( 71.6; 80.8) |
51.7 |
( 42.8; 60.5) |
| 18 |
5090 |
3760 |
7475 |
68.1 |
68.0 |
( 66.9; 69.1) |
35.4 |
( 33.2; 37.6) |
| 16 |
9476 |
9002 |
17831 |
53.1 |
52.9 |
( 52.2; 53.6) |
5.3 |
( 3.9; 6.7) |
| 06 |
7557 |
7224 |
13878 |
54.5 |
52.6 |
( 51.8; 53.4) |
4.6 |
( 3.1; 6.1) |
| 12 |
3472 |
3496 |
7187 |
48.3 |
49.9 |
( 48.7; 51.1) |
-0.7 |
( -3.1; 1.7) |
| 04 |
7305 |
8426 |
16958 |
43.1 |
43.6 |
( 42.8; 44.3) |
-13.3 |
(-14.8;-11.8) |
| 10 |
3156 |
3949 |
8070 |
39.1 |
40.2 |
( 39.1; 41.2) |
-20.1 |
(-22.3;-17.9) |
| 08 |
415 |
529 |
1111 |
37.4 |
39.4 |
( 36.4; 42.4) |
-21.6 |
(-27.9;-15.2) |
| 09 |
504 |
691 |
1306 |
38.6 |
36.6 |
( 34.1; 39.2) |
-27.1 |
(-31.8;-22.3) |
| T |
37292 |
|
74216 |
50.2 |
|
|
|
|
Table 5.2.9.2.4 - Standardized Estimates:
5.2.9.2 Oral therapy in adults w diabetes: Biguanides
(Type of Diabetes = Type 2 )
|
Barplots (Adjusted Rates): 5.2.9.2.2 5.2.9.2 Oral therapy in adults w diabetes: Biguanides - Type of Diabetes = Type 2
|
Forest plots: 5.2.9.2.2 5.2.9.2 Oral therapy in adults w diabetes: Biguanides - Type of Diabetes = Type 2
